speb/financial-data huggingface dataset:
SYP.DE balance_sheet (annual, 2025-10-31) — Minority Interest: -587000.00
SYP.DE balance_sheet (quarterly, 2025-10-31) — Minority Interest: -587000.00
SYP.DE income_statement (annual, 2025-10-31) — Minority Interests: -1031000.00
SYP.DE income_statement (quarterly, 2025-10-31) — Minority Interests: 243000.00
SYP.DE cash_flow (annual, 2025-10-31) — Net Business Purchase And Sale: -15934707000.00
SYP.DE cash_flow (quarterly, 2025-10-31) — Net Business Purchase And Sale: 604004000.00
SYP.DE cash_flow (annual, 2025-10-31) — Net Common Stock Issuance: 228418000.00
SYP.DE cash_flow (quarterly, 2025-10-31) — Net Common Stock Issuance: 90317000.00
SYP.DE balance_sheet (annual, 2025-10-31) — Net Debt: 10596485000.00
SYP.DE balance_sheet (quarterly, 2025-10-31) — Net Debt: 10596485000.00
SYP.DE income_statement (annual, 2025-10-31) — Net Income: 1332220000.00
SYP.DE income_statement (quarterly, 2025-10-31) — Net Income: 448696000.00
SYP.DE income_statement (annual, 2025-10-31) — Net Income Common Stockholders: 1332220000.00
SYP.DE income_statement (quarterly, 2025-10-31) — Net Income Common Stockholders: 448696000.00
SYP.DE income_statement (annual, 2025-10-31) — Net Income Continuous Operations: 1337151000.00
SYP.DE income_statement (quarterly, 2025-10-31) — Net Income Continuous Operations: 448453000.00
SYP.DE income_statement (annual, 2025-10-31) — Net Income Discontinuous Operations: -3900000.00
SYP.DE income_statement (quarterly, 2025-10-31) — Net Income Discontinuous Operations: 0.00
SYP.DE income_statement (annual, 2025-10-31) — Net Income From Continuing And Discontinued Operation: 1332220000.00
SYP.DE income_statement (quarterly, 2025-10-31) — Net Income From Continuing And Discontinued Operation: 448696000.00
SYP.DE income_statement (annual, 2025-10-31) — Net Income From Continuing Operation Net Minority Interest: 1336120000.00
SYP.DE income_statement (quarterly, 2025-10-31) — Net Income From Continuing Operation Net Minority Interest: 448696000.00
SYP.DE cash_flow (annual, 2025-10-31) — Net Income From Continuing Operations: 1333251000.00
SYP.DE cash_flow (quarterly, 2025-10-31) — Net Income From Continuing Operations: 448453000.00
SYP.DE income_statement (annual, 2025-10-31) — Net Income Including Noncontrolling Interests: 1333251000.00
SYP.DE income_statement (quarterly, 2025-10-31) — Net Income Including Noncontrolling Interests: 448453000.00
SYP.DE income_statement (annual, 2025-10-31) — Net Interest Income: -169045000.00
SYP.DE income_statement (quarterly, 2025-10-31) — Net Interest Income: -174095000.00
SYP.DE cash_flow (annual, 2025-10-31) — Net Investment Purchase And Sale: 148978000.00
SYP.DE cash_flow (quarterly, 2025-10-31) — Net Investment Purchase And Sale: -5287000.00
SYP.DE cash_flow (annual, 2025-10-31) — Net Issuance Payments Of Debt: 13465703000.00
SYP.DE cash_flow (quarterly, 2025-10-31) — Net Issuance Payments Of Debt: -861058000.00
SYP.DE cash_flow (annual, 2025-10-31) — Net Long Term Debt Issuance: 13465703000.00
SYP.DE cash_flow (quarterly, 2025-10-31) — Net Long Term Debt Issuance: -861058000.00
SYP.DE income_statement (annual, 2025-10-31) — Net Non Operating Interest Income Expense: -169045000.00
SYP.DE income_statement (quarterly, 2025-10-31) — Net Non Operating Interest Income Expense: -174095000.00
SYP.DE cash_flow (annual, 2025-10-31) — Net Other Financing Charges: -338364000.00
SYP.DE cash_flow (quarterly, 2025-10-31) — Net Other Financing Charges: -65110000.00
SYP.DE cash_flow (annual, 2025-10-31) — Net Other Investing Changes: -365000.00
SYP.DE cash_flow (quarterly, 2025-10-31) — Net Other Investing Changes: 246000.00
SYP.DE balance_sheet (annual, 2025-10-31) — Net PPE: 1398701000.00
SYP.DE balance_sheet (quarterly, 2025-10-31) — Net PPE: 1398701000.00
SYP.DE cash_flow (annual, 2025-10-31) — Net PPE Purchase And Sale: -95175000.00
SYP.DE cash_flow (quarterly, 2025-10-31) — Net PPE Purchase And Sale: -34546000.00
SYP.DE balance_sheet (annual, 2025-10-31) — Net Tangible Assets: -11251204000.00
SYP.DE balance_sheet (quarterly, 2025-10-31) — Net Tangible Assets: -11251204000.00
SYP.DE balance_sheet (annual, 2025-10-31) — Non Current Deferred Assets: 112159000.00
SYP.DE balance_sheet (quarterly, 2025-10-31) — Non Current Deferred Assets: 112159000.00
SYP.DE balance_sheet (annual, 2025-10-31) — Non Current Deferred Liabilities: 1830859000.00
SYP.DE balance_sheet (quarterly, 2025-10-31) — Non Current Deferred Liabilities: 1830859000.00
SYP.DE balance_sheet (annual, 2025-10-31) — Non Current Deferred Revenue: 382557000.00
SYP.DE balance_sheet (quarterly, 2025-10-31) — Non Current Deferred Revenue: 382557000.00
SYP.DE balance_sheet (annual, 2025-10-31) — Non Current Deferred Taxes Assets: 112159000.00
SYP.DE balance_sheet (quarterly, 2025-10-31) — Non Current Deferred Taxes Assets: 112159000.00
SYP.DE balance_sheet (annual, 2025-10-31) — Non Current Deferred Taxes Liabilities: 1001070000.00
SYP.DE balance_sheet (quarterly, 2025-10-31) — Non Current Deferred Taxes Liabilities: 1001070000.00
SYP.DE income_statement (annual, 2025-10-31) — Normalized EBITDA: 1901803000.00
SYP.DE income_statement (quarterly, 2025-10-31) — Normalized EBITDA: 610757000.00
SYP.DE income_statement (annual, 2025-10-31) — Normalized Income: 761561920.00
SYP.DE income_statement (quarterly, 2025-10-31) — Normalized Income: -28510487.65
SYP.DE cash_flow (annual, 2025-10-31) — Operating Cash Flow: 1518608000.00
SYP.DE cash_flow (quarterly, 2025-10-31) — Operating Cash Flow: 639738000.00
SYP.DE cash_flow (annual, 2025-10-31) — Operating Gains Losses: -555794000.00
SYP.DE cash_flow (quarterly, 2025-10-31) — Operating Gains Losses: -516343000.00
SYP.DE income_statement (annual, 2025-10-31) — Operating Income: 914927000.00
SYP.DE income_statement (quarterly, 2025-10-31) — Operating Income: 121393000.00
SYP.DE income_statement (annual, 2025-10-31) — Operating Revenue: 7054178000.00
SYP.DE income_statement (quarterly, 2025-10-31) — Operating Revenue: 2254860000.00
SYP.DE balance_sheet (annual, 2025-10-31) — Ordinary Shares Number: 185994000.00
SYP.DE balance_sheet (quarterly, 2025-10-31) — Ordinary Shares Number: 185994000.00
SYP.DE balance_sheet (annual, 2025-10-31) — Other Current Assets: 1180526000.00
SYP.DE balance_sheet (quarterly, 2025-10-31) — Other Current Assets: 1180526000.00
SYP.DE balance_sheet (annual, 2025-10-31) — Other Current Borrowings: 22117000.00
SYP.DE balance_sheet (quarterly, 2025-10-31) — Other Current Borrowings: 22117000.00
SYP.DE balance_sheet (annual, 2025-10-31) — Other Equity Adjustments: -232414000.00
SYP.DE balance_sheet (quarterly, 2025-10-31) — Other Equity Adjustments: -232414000.00
SYP.DE income_statement (annual, 2025-10-31) — Other Gand A: 769648000.00
SYP.DE income_statement (quarterly, 2025-10-31) — Other Gand A: 185515000.00
SYP.DE income_statement (annual, 2025-10-31) — Other Income Expense: 647260000.00
SYP.DE income_statement (quarterly, 2025-10-31) — Other Income Expense: 569226000.00
SYP.DE balance_sheet (annual, 2025-10-31) — Other Intangible Assets: 12679591000.00
SYP.DE balance_sheet (quarterly, 2025-10-31) — Other Intangible Assets: 12679591000.00
SYP.DE cash_flow (annual, 2025-10-31) — Other Non Cash Items: 103822000.00
SYP.DE cash_flow (quarterly, 2025-10-31) — Other Non Cash Items: 57707000.00
SYP.DE balance_sheet (annual, 2025-10-31) — Other Non Current Assets: 1122693000.00
SYP.DE balance_sheet (quarterly, 2025-10-31) — Other Non Current Assets: 1122693000.00
SYP.DE balance_sheet (annual, 2025-10-31) — Other Non Current Liabilities: 200997000.00
SYP.DE balance_sheet (quarterly, 2025-10-31) — Other Non Current Liabilities: 200997000.00
SYP.DE income_statement (annual, 2025-10-31) — Other Non Operating Income Expenses: 48762000.00
SYP.DE income_statement (quarterly, 2025-10-31) — Other Non Operating Income Expenses: 19584000.00
SYP.DE balance_sheet (annual, 2025-10-31) — Other Properties: 702008000.00
SYP.DE balance_sheet (quarterly, 2025-10-31) — Other Properties: 702008000.00
SYP.DE balance_sheet (annual, 2025-10-31) — Other Receivables: 45528000.00
SYP.DE balance_sheet (quarterly, 2025-10-31) — Other Receivables: 45528000.00
SYP.DE balance_sheet (annual, 2025-10-31) — Other Short Term Investments: 72929000.00
SYP.DE balance_sheet (quarterly, 2025-10-31) — Other Short Term Investments: 72929000.00
SYP.DE balance_sheet (annual, 2025-10-31) — Payables: 259430000.00
SYP.DE balance_sheet (quarterly, 2025-10-31) — Payables: 259430000.00
SYP.DE balance_sheet (annual, 2025-10-31) — Payables And Accrued Expenses: 1326211000.00
SYP.DE balance_sheet (quarterly, 2025-10-31) — Payables And Accrued Expenses: 1326211000.00
SYP.DE balance_sheet (annual, 2025-10-31) — Preferred Stock: 0.00
SYP.DE balance_sheet (quarterly, 2025-10-31) — Preferred Stock: 0.00
SYP.DE income_statement (annual, 2025-10-31) — Pretax Income: 1393142000.00
SYP.DE income_statement (quarterly, 2025-10-31) — Pretax Income: 516524000.00
SYP.DE balance_sheet (annual, 2025-10-31) — Properties: 0.00
SYP.DE balance_sheet (quarterly, 2025-10-31) — Properties: 0.00
SYP.DE cash_flow (annual, 2025-10-31) — Provisionand Write Offof Assets: 50891000.00
SYP.DE cash_flow (quarterly, 2025-10-31) — Provisionand Write Offof Assets: 27332000.00
SYP.DE cash_flow (annual, 2025-10-31) — Purchase Of Business: -16681257000.00
SYP.DE cash_flow (quarterly, 2025-10-31) — Purchase Of Business: 0.00
SYP.DE cash_flow (annual, 2025-10-31) — Purchase Of Investment: -69808000.00
SYP.DE cash_flow (quarterly, 2025-10-31) — Purchase Of Investment: -18164000.00
SYP.DE cash_flow (annual, 2025-10-31) — Purchase Of PPE: -169454000.00
SYP.DE cash_flow (quarterly, 2025-10-31) — Purchase Of PPE: -34546000.00
SYP.DE balance_sheet (annual, 2025-10-31) — Receivables: 1505427000.00
SYP.DE balance_sheet (quarterly, 2025-10-31) — Receivables: 1505427000.00
SYP.DE balance_sheet (annual, 2025-10-31) — Receivables Adjustments Allowances: -88959000.00
SYP.DE balance_sheet (quarterly, 2025-10-31) — Receivables Adjustments Allowances: -88959000.00
SYP.DE income_statement (annual, 2025-10-31) — Reconciled Cost Of Revenue: 1155644000.00
SYP.DE income_statement (quarterly, 2025-10-31) — Reconciled Cost Of Revenue: 361496000.00
SYP.DE income_statement (annual, 2025-10-31) — Reconciled Depreciation: 660430000.00
SYP.DE income_statement (quarterly, 2025-10-31) — Reconciled Depreciation: 449123000.00
SYP.DE cash_flow (annual, 2025-10-31) — Repayment Of Debt: -863637000.00
SYP.DE cash_flow (quarterly, 2025-10-31) — Repayment Of Debt: -861058000.00
SYP.DE cash_flow (annual, 2025-10-31) — Repurchase Of Capital Stock: 0.00
SYP.DE income_statement (annual, 2025-10-31) — Research And Development: 2479338000.00
SYP.DE income_statement (quarterly, 2025-10-31) — Research And Development: 746842000.00
SYP.DE income_statement (annual, 2025-10-31) — Restructuring And Mergern Acquisition: 0.00
SYP.DE balance_sheet (annual, 2025-10-31) — Retained Earnings: 10315487000.00
SYP.DE balance_sheet (quarterly, 2025-10-31) — Retained Earnings: 10315487000.00
SYP.DE cash_flow (annual, 2025-10-31) — Sale Of Business: 746550000.00
SYP.DE cash_flow (quarterly, 2025-10-31) — Sale Of Business: 604004000.00
SYP.DE cash_flow (annual, 2025-10-31) — Sale Of Investment: 218786000.00
SYP.DE cash_flow (quarterly, 2025-10-31) — Sale Of Investment: 12877000.00
SYP.DE cash_flow (annual, 2025-10-31) — Sale Of PPE: 74279000.00
SYP.DE cash_flow (quarterly, 2025-10-31) — Sale Of PPE: 0.00
SYP.DE income_statement (annual, 2025-10-31) — Selling And Marketing Expense: 1074191000.00
SYP.DE income_statement (quarterly, 2025-10-31) — Selling And Marketing Expense: 390491000.00
SYP.DE income_statement (annual, 2025-10-31) — Selling General And Administration: 1843839000.00
SYP.DE income_statement (quarterly, 2025-10-31) — Selling General And Administration: 576006000.00
SYP.DE balance_sheet (annual, 2025-10-31) — Share Issued: 187216000.00
SYP.DE balance_sheet (quarterly, 2025-10-31) — Share Issued: 187216000.00
SYP.DE income_statement (annual, 2025-10-31) — Special Income Charges: 596656000.00
SYP.DE income_statement (quarterly, 2025-10-31) — Special Income Charges: 548906000.00
SYP.DE cash_flow (annual, 2025-10-31) — Stock Based Compensation: 893294000.00
SYP.DE cash_flow (quarterly, 2025-10-31) — Stock Based Compensation: 237385000.00
SYP.DE balance_sheet (annual, 2025-10-31) — Stockholders Equity: 28327602000.00
SYP.DE balance_sheet (quarterly, 2025-10-31) — Stockholders Equity: 28327602000.00
SYP.DE balance_sheet (annual, 2025-10-31) — Tangible Book Value: -11251204000.00
SYP.DE balance_sheet (quarterly, 2025-10-31) — Tangible Book Value: -11251204000.00
SYP.DE income_statement (annual, 2025-10-31) — Tax Effect Of Unusual Items: 23939920.00
SYP.DE income_statement (quarterly, 2025-10-31) — Tax Effect Of Unusual Items: 72435512.35
SYP.DE income_statement (annual, 2025-10-31) — Tax Provision: 55991000.00
SYP.DE income_statement (quarterly, 2025-10-31) — Tax Provision: 68071000.00
SYP.DE income_statement (annual, 2025-10-31) — Tax Rate For Calcs: 0.04
SYP.DE income_statement (quarterly, 2025-10-31) — Tax Rate For Calcs: 0.13
SYP.DE balance_sheet (annual, 2025-10-31) — Total Assets: 48224461000.00
SYP.DE balance_sheet (quarterly, 2025-10-31) — Total Assets: 48224461000.00
SYP.DE balance_sheet (annual, 2025-10-31) — Total Capitalization: 41790000000.00
SYP.DE balance_sheet (quarterly, 2025-10-31) — Total Capitalization: 41790000000.00
SYP.DE balance_sheet (annual, 2025-10-31) — Total Debt: 14293418000.00
SYP.DE balance_sheet (quarterly, 2025-10-31) — Total Debt: 14293418000.00
SYP.DE balance_sheet (annual, 2025-10-31) — Total Equity Gross Minority Interest: 28327015000.00
SYP.DE balance_sheet (quarterly, 2025-10-31) — Total Equity Gross Minority Interest: 28327015000.00
SYP.DE income_statement (annual, 2025-10-31) — Total Expenses: 6139251000.00
SYP.DE income_statement (quarterly, 2025-10-31) — Total Expenses: 2133467000.00
SYP.DE balance_sheet (annual, 2025-10-31) — Total Liabilities Net Minority Interest: 19897446000.00
SYP.DE balance_sheet (quarterly, 2025-10-31) — Total Liabilities Net Minority Interest: 19897446000.00
SYP.DE balance_sheet (annual, 2025-10-31) — Total Non Current Assets: 42212359000.00
SYP.DE balance_sheet (quarterly, 2025-10-31) — Total Non Current Assets: 42212359000.00
SYP.DE balance_sheet (annual, 2025-10-31) — Total Non Current Liabilities Net Minority Interest: 16174952000.00
SYP.DE balance_sheet (quarterly, 2025-10-31) — Total Non Current Liabilities Net Minority Interest: 16174952000.00
SYP.DE income_statement (annual, 2025-10-31) — Total Operating Income As Reported: 914927000.00
SYP.DE income_statement (quarterly, 2025-10-31) — Total Operating Income As Reported: 121393000.00
SYP.DE balance_sheet (annual, 2025-10-31) — Total Tax Payable: 94664000.00
SYP.DE balance_sheet (quarterly, 2025-10-31) — Total Tax Payable: 94664000.00
SYP.DE income_statement (annual, 2025-10-31) — Total Unusual Items: 598498000.00
SYP.DE income_statement (quarterly, 2025-10-31) — Total Unusual Items: 549642000.00
SYP.DE income_statement (annual, 2025-10-31) — Total Unusual Items Excluding Goodwill: 598498000.00
SYP.DE income_statement (quarterly, 2025-10-31) — Total Unusual Items Excluding Goodwill: 549642000.00
SYP.DE balance_sheet (annual, 2025-10-31) — Treasury Shares Number: 1222000.00
SYP.DE balance_sheet (quarterly, 2025-10-31) — Treasury Shares Number: 1222000.00
SYP.DE balance_sheet (annual, 2025-10-31) — Treasury Stock: 398278000.00
SYP.DE balance_sheet (quarterly, 2025-10-31) — Treasury Stock: 398278000.00
SYP.DE balance_sheet (annual, 2025-10-31) — Working Capital: 2289608000.00
SYP.DE balance_sheet (quarterly, 2025-10-31) — Working Capital: 2289608000.00
SYP.DE income_statement (quarterly, 2026-01-31) — +Operating Expense: 1450088000.00
SYP.DE income_statement (quarterly, 2026-01-31) — +Total Revenue: 2408798000.00
SYP.DE balance_sheet (quarterly, 2026-01-31) — Accounts Payable: 113263000.00
SYP.DE balance_sheet (quarterly, 2026-01-31) — Accounts Receivable: 1640665000.00
SYP.DE balance_sheet (quarterly, 2026-01-31) — Additional Paid In Capital: 20562001000.00
SYP.DE income_statement (quarterly, 2026-01-31) — Amortization: 155993000.00
SYP.DE income_statement (quarterly, 2026-01-31) — Amortization Of Intangibles Income Statement: 155993000.00
SYP.DE balance_sheet (quarterly, 2026-01-31) — Assets Held For Sale Current: 48152000.00
SYP.DE income_statement (quarterly, 2026-01-31) — Basic Average Shares: 189593000.00
SYP.DE income_statement (quarterly, 2026-01-31) — Basic EPS: 0.34
SYP.DE cash_flow (quarterly, 2026-01-31) — Beginning Cash Position: 2893721000.00
SYP.DE cash_flow (quarterly, 2026-01-31) — Capital Expenditure: -35320000.00
SYP.DE balance_sheet (quarterly, 2026-01-31) — Capital Lease Obligations: 824347000.00
SYP.DE balance_sheet (quarterly, 2026-01-31) — Capital Stock: 1915000.00
SYP.DE balance_sheet (quarterly, 2026-01-31) — Cash And Cash Equivalents: 2129572000.00
SYP.DE balance_sheet (quarterly, 2026-01-31) — Cash Cash Equivalents And Short Term Investments: 2203482000.00
SYP.DE cash_flow (quarterly, 2026-01-31) — Cash Flow From Continuing Financing Activities: -1583165000.00
SYP.DE cash_flow (quarterly, 2026-01-31) — Cash Flow From Continuing Investing Activities: -36506000.00
SYP.DE cash_flow (quarterly, 2026-01-31) — Cash Flow From Continuing Operating Activities: 856832000.00
SYP.DE cash_flow (quarterly, 2026-01-31) — Change In Inventory: -29382000.00
SYP.DE cash_flow (quarterly, 2026-01-31) — Change In Other Current Assets: -81413000.00
SYP.DE cash_flow (quarterly, 2026-01-31) — Change In Other Current Liabilities: -32345000.00
SYP.DE cash_flow (quarterly, 2026-01-31) — Change In Other Working Capital: 282676000.00
SYP.DE cash_flow (quarterly, 2026-01-31) — Change In Payables And Accrued Expense: -37286000.00
SYP.DE cash_flow (quarterly, 2026-01-31) — Change In Prepaid Assets: 84616000.00
SYP.DE cash_flow (quarterly, 2026-01-31) — Change In Receivables: -128651000.00
SYP.DE cash_flow (quarterly, 2026-01-31) — Change In Working Capital: 58215000.00
SYP.DE cash_flow (quarterly, 2026-01-31) — Changes In Account Receivables: -128651000.00
SYP.DE cash_flow (quarterly, 2026-01-31) — Changes In Cash: -762839000.00
SYP.DE balance_sheet (quarterly, 2026-01-31) — Common Stock: 1915000.00
SYP.DE balance_sheet (quarterly, 2026-01-31) — Common Stock Equity: 30548827000.00
SYP.DE cash_flow (quarterly, 2026-01-31) — Common Stock Issuance: 2012742000.00
SYP.DE income_statement (quarterly, 2026-01-31) — Cost Of Revenue: 637382000.00
SYP.DE balance_sheet (quarterly, 2026-01-31) — Current Accrued Expenses: 1079865000.00
SYP.DE balance_sheet (quarterly, 2026-01-31) — Current Assets: 5373638000.00
SYP.DE balance_sheet (quarterly, 2026-01-31) — Current Capital Lease Obligation: 133098000.00
SYP.DE balance_sheet (quarterly, 2026-01-31) — Current Debt: 22117000.00
SYP.DE balance_sheet (quarterly, 2026-01-31) — Current Debt And Capital Lease Obligation: 155215000.00
SYP.DE balance_sheet (quarterly, 2026-01-31) — Current Deferred Liabilities: 2459122000.00
SYP.DE balance_sheet (quarterly, 2026-01-31) — Current Deferred Revenue: 2459122000.00
SYP.DE balance_sheet (quarterly, 2026-01-31) — Current Liabilities: 3942650000.00
SYP.DE cash_flow (quarterly, 2026-01-31) — Deferred Income Tax: -51776000.00
SYP.DE cash_flow (quarterly, 2026-01-31) — Deferred Tax: -51776000.00
SYP.DE cash_flow (quarterly, 2026-01-31) — Depreciation Amortization Depletion: 450688000.00
SYP.DE income_statement (quarterly, 2026-01-31) — Depreciation Amortization Depletion Income Statement: 155993000.00
SYP.DE cash_flow (quarterly, 2026-01-31) — Depreciation And Amortization: 450688000.00
SYP.DE income_statement (quarterly, 2026-01-31) — Depreciation And Amortization In Income Statement: 155993000.00
SYP.DE income_statement (quarterly, 2026-01-31) — Diluted Average Shares: 190762000.00
SYP.DE income_statement (quarterly, 2026-01-31) — Diluted EPS: 0.34
SYP.DE income_statement (quarterly, 2026-01-31) — Diluted NI Availto Com Stockholders: 64958000.00
SYP.DE income_statement (quarterly, 2026-01-31) — EBIT: 241768000.00
SYP.DE income_statement (quarterly, 2026-01-31) — EBITDA: 692456000.00
SYP.DE cash_flow (quarterly, 2026-01-31) — Effect Of Exchange Rate Changes: 3432000.00
SYP.DE cash_flow (quarterly, 2026-01-31) — End Cash Position: 2134314000.00
SYP.DE cash_flow (quarterly, 2026-01-31) — Financing Cash Flow: -1583165000.00
SYP.DE cash_flow (quarterly, 2026-01-31) — Free Cash Flow: 821512000.00
SYP.DE income_statement (quarterly, 2026-01-31) — Gain On Sale Of Security: -5828000.00
SYP.DE balance_sheet (quarterly, 2026-01-31) — Gains Losses Not Affecting Retained Earnings: -203683000.00
SYP.DE income_statement (quarterly, 2026-01-31) — General And Administrative Expense: 182732000.00
SYP.DE balance_sheet (quarterly, 2026-01-31) — Goodwill: 26880889000.00
SYP.DE balance_sheet (quarterly, 2026-01-31) — Goodwill And Other Intangible Assets: 39170418000.00
SYP.DE balance_sheet (quarterly, 2026-01-31) — Gross PPE: 1390287000.00
SYP.DE income_statement (quarterly, 2026-01-31) — Gross Profit: 1771416000.00
SYP.DE balance_sheet (quarterly, 2026-01-31) — Income Tax Payable: 111560000.00
SYP.DE income_statement (quarterly, 2026-01-31) — Interest Expense: 162715000.00
SYP.DE income_statement (quarterly, 2026-01-31) — Interest Expense Non Operating: 162715000.00
SYP.DE income_statement (quarterly, 2026-01-31) — Interest Income: 17433000.00
SYP.DE income_statement (quarterly, 2026-01-31) — Interest Income Non Operating: 17433000.00
SYP.DE balance_sheet (quarterly, 2026-01-31) — Interest Payable: 170480000.00
SYP.DE balance_sheet (quarterly, 2026-01-31) — Inventory: 393221000.00
SYP.DE balance_sheet (quarterly, 2026-01-31) — Invested Capital: 40593037000.00
SYP.DE cash_flow (quarterly, 2026-01-31) — Investing Cash Flow: -36506000.00
SYP.DE cash_flow (quarterly, 2026-01-31) — Issuance Of Capital Stock: 2012742000.00
SYP.DE balance_sheet (quarterly, 2026-01-31) — Long Term Capital Lease Obligation: 691249000.00
SYP.DE balance_sheet (quarterly, 2026-01-31) — Long Term Debt: 10022093000.00
SYP.DE balance_sheet (quarterly, 2026-01-31) — Long Term Debt And Capital Lease Obligation: 10713342000.00
SYP.DE cash_flow (quarterly, 2026-01-31) — Long Term Debt Payments: -3451310000.00
SYP.DE balance_sheet (quarterly, 2026-01-31) — Minority Interest: -829000.00
SYP.DE income_statement (quarterly, 2026-01-31) — Minority Interests: -242000.00
SYP.DE cash_flow (quarterly, 2026-01-31) — Net Business Purchase And Sale: 0.00
SYP.DE cash_flow (quarterly, 2026-01-31) — Net Common Stock Issuance: 2012742000.00
SYP.DE balance_sheet (quarterly, 2026-01-31) — Net Debt: 7914638000.00
SYP.DE income_statement (quarterly, 2026-01-31) — Net Income: 64958000.00
SYP.DE income_statement (quarterly, 2026-01-31) — Net Income Common Stockholders: 64958000.00
SYP.DE income_statement (quarterly, 2026-01-31) — Net Income Continuous Operations: 64716000.00
SYP.DE income_statement (quarterly, 2026-01-31) — Net Income Discontinuous Operations: 484000.00
SYP.DE income_statement (quarterly, 2026-01-31) — Net Income From Continuing And Discontinued Operation: 64958000.00
SYP.DE income_statement (quarterly, 2026-01-31) — Net Income From Continuing Operation Net Minority Interest: 64474000.00
SYP.DE cash_flow (quarterly, 2026-01-31) — Net Income From Continuing Operations: 64716000.00
SYP.DE income_statement (quarterly, 2026-01-31) — Net Income Including Noncontrolling Interests: 65200000.00
SYP.DE income_statement (quarterly, 2026-01-31) — Net Interest Income: -145282000.00
SYP.DE cash_flow (quarterly, 2026-01-31) — Net Investment Purchase And Sale: -1186000.00
SYP.DE cash_flow (quarterly, 2026-01-31) — Net Issuance Payments Of Debt: -3451310000.00
SYP.DE cash_flow (quarterly, 2026-01-31) — Net Long Term Debt Issuance: -3451310000.00
SYP.DE income_statement (quarterly, 2026-01-31) — Net Non Operating Interest Income Expense: -145282000.00
SYP.DE cash_flow (quarterly, 2026-01-31) — Net Other Financing Charges: -144597000.00
SYP.DE balance_sheet (quarterly, 2026-01-31) — Net PPE: 1390287000.00
SYP.DE cash_flow (quarterly, 2026-01-31) — Net PPE Purchase And Sale: -35320000.00
SYP.DE balance_sheet (quarterly, 2026-01-31) — Net Tangible Assets: -8621591000.00
SYP.DE balance_sheet (quarterly, 2026-01-31) — Non Current Deferred Assets: 117386000.00
SYP.DE balance_sheet (quarterly, 2026-01-31) — Non Current Deferred Liabilities: 1839878000.00
SYP.DE balance_sheet (quarterly, 2026-01-31) — Non Current Deferred Revenue: 420887000.00
SYP.DE balance_sheet (quarterly, 2026-01-31) — Non Current Deferred Taxes Assets: 117386000.00
SYP.DE balance_sheet (quarterly, 2026-01-31) — Non Current Deferred Taxes Liabilities: 954115000.00
SYP.DE income_statement (quarterly, 2026-01-31) — Normalized EBITDA: 816566000.00
SYP.DE income_statement (quarterly, 2026-01-31) — Normalized Income: 166120090.00
SYP.DE cash_flow (quarterly, 2026-01-31) — Operating Cash Flow: 856832000.00
SYP.DE income_statement (quarterly, 2026-01-31) — Operating Income: 321328000.00
SYP.DE income_statement (quarterly, 2026-01-31) — Operating Revenue: 2408798000.00
SYP.DE balance_sheet (quarterly, 2026-01-31) — Ordinary Shares Number: 191449000.00
SYP.DE balance_sheet (quarterly, 2026-01-31) — Other Current Assets: 1088118000.00
SYP.DE balance_sheet (quarterly, 2026-01-31) — Other Current Borrowings: 22117000.00
SYP.DE balance_sheet (quarterly, 2026-01-31) — Other Current Liabilities: 23625000.00
SYP.DE balance_sheet (quarterly, 2026-01-31) — Other Equity Adjustments: -203683000.00
SYP.DE income_statement (quarterly, 2026-01-31) — Other Gand A: 182732000.00
SYP.DE income_statement (quarterly, 2026-01-31) — Other Income Expense: -96993000.00
SYP.DE balance_sheet (quarterly, 2026-01-31) — Other Intangible Assets: 12289529000.00
SYP.DE cash_flow (quarterly, 2026-01-31) — Other Non Cash Items: 68059000.00
SYP.DE balance_sheet (quarterly, 2026-01-31) — Other Non Current Assets: 1186199000.00
SYP.DE balance_sheet (quarterly, 2026-01-31) — Other Non Current Liabilities: 194060000.00
SYP.DE income_statement (quarterly, 2026-01-31) — Other Non Operating Income Expenses: 27117000.00
SYP.DE balance_sheet (quarterly, 2026-01-31) — Other Properties: 1390287000.00
SYP.DE balance_sheet (quarterly, 2026-01-31) — Other Short Term Investments: 73910000.00
SYP.DE balance_sheet (quarterly, 2026-01-31) — Payables: 224823000.00
SYP.DE balance_sheet (quarterly, 2026-01-31) — Payables And Accrued Expenses: 1304688000.00
SYP.DE balance_sheet (quarterly, 2026-01-31) — Preferred Stock: 0.00
SYP.DE income_statement (quarterly, 2026-01-31) — Pretax Income: 79053000.00
SYP.DE cash_flow (quarterly, 2026-01-31) — Provisionand Write Offof Assets: 8206000.00
SYP.DE cash_flow (quarterly, 2026-01-31) — Purchase Of Investment: -4904000.00
SYP.DE cash_flow (quarterly, 2026-01-31) — Purchase Of PPE: -35320000.00
SYP.DE balance_sheet (quarterly, 2026-01-31) — Receivables: 1640665000.00
SYP.DE income_statement (quarterly, 2026-01-31) — Reconciled Cost Of Revenue: 342687000.00
SYP.DE income_statement (quarterly, 2026-01-31) — Reconciled Depreciation: 450688000.00
SYP.DE cash_flow (quarterly, 2026-01-31) — Repayment Of Debt: -3451310000.00
SYP.DE income_statement (quarterly, 2026-01-31) — Research And Development: 714988000.00
SYP.DE income_statement (quarterly, 2026-01-31) — Restructuring And Mergern Acquisition: 118282000.00
SYP.DE balance_sheet (quarterly, 2026-01-31) — Retained Earnings: 10380445000.00
SYP.DE cash_flow (quarterly, 2026-01-31) — Sale Of Business: 0.00
SYP.DE cash_flow (quarterly, 2026-01-31) — Sale Of Investment: 3718000.00
SYP.DE income_statement (quarterly, 2026-01-31) — Selling And Marketing Expense: 396375000.00
SYP.DE income_statement (quarterly, 2026-01-31) — Selling General And Administration: 579107000.00
SYP.DE balance_sheet (quarterly, 2026-01-31) — Share Issued: 192038000.00
SYP.DE income_statement (quarterly, 2026-01-31) — Special Income Charges: -118282000.00
SYP.DE cash_flow (quarterly, 2026-01-31) — Stock Based Compensation: 258724000.00
SYP.DE balance_sheet (quarterly, 2026-01-31) — Stockholders Equity: 30548827000.00
SYP.DE balance_sheet (quarterly, 2026-01-31) — Tangible Book Value: -8621591000.00
SYP.DE income_statement (quarterly, 2026-01-31) — Tax Effect Of Unusual Items: -22463910.00
SYP.DE income_statement (quarterly, 2026-01-31) — Tax Provision: 14337000.00
SYP.DE income_statement (quarterly, 2026-01-31) — Tax Rate For Calcs: 0.18
SYP.DE balance_sheet (quarterly, 2026-01-31) — Total Assets: 47237928000.00
SYP.DE balance_sheet (quarterly, 2026-01-31) — Total Capitalization: 40570920000.00
SYP.DE balance_sheet (quarterly, 2026-01-31) — Total Debt: 10868557000.00
SYP.DE balance_sheet (quarterly, 2026-01-31) — Total Equity Gross Minority Interest: 30547998000.00
SYP.DE income_statement (quarterly, 2026-01-31) — Total Expenses: 2087470000.00
SYP.DE balance_sheet (quarterly, 2026-01-31) — Total Liabilities Net Minority Interest: 16689930000.00
SYP.DE balance_sheet (quarterly, 2026-01-31) — Total Non Current Assets: 41864290000.00
SYP.DE balance_sheet (quarterly, 2026-01-31) — Total Non Current Liabilities Net Minority Interest: 12747280000.00
SYP.DE income_statement (quarterly, 2026-01-31) — Total Operating Income As Reported: 203046000.00
SYP.DE balance_sheet (quarterly, 2026-01-31) — Total Tax Payable: 111560000.00
SYP.DE income_statement (quarterly, 2026-01-31) — Total Unusual Items: -124110000.00
SYP.DE income_statement (quarterly, 2026-01-31) — Total Unusual Items Excluding Goodwill: -124110000.00
SYP.DE balance_sheet (quarterly, 2026-01-31) — Treasury Shares Number: 589000.00
SYP.DE balance_sheet (quarterly, 2026-01-31) — Treasury Stock: 191851000.00
SYP.DE balance_sheet (quarterly, 2026-01-31) — Working Capital: 1430988000.00
SYP.DE income_statement (quarterly, 2026-04-30) — +Operating Expense: 1409815000.00
SYP.DE income_statement (quarterly, 2026-04-30) — +Total Revenue: 2275985000.00
SYP.DE balance_sheet (quarterly, 2026-04-30) — Accounts Payable: 179257000.00
SYP.DE balance_sheet (quarterly, 2026-04-30) — Accounts Receivable: 1267305000.00
SYP.DE balance_sheet (quarterly, 2026-04-30) — Additional Paid In Capital: 20565562000.00
SYP.DE income_statement (quarterly, 2026-04-30) — Amortization: 155275000.00
SYP.DE income_statement (quarterly, 2026-04-30) — Amortization Of Intangibles Income Statement: 155275000.00
SYP.DE balance_sheet (quarterly, 2026-04-30) — Assets Held For Sale Current: 48248000.00
SYP.DE income_statement (quarterly, 2026-04-30) — Basic Average Shares: 191464000.00
SYP.DE income_statement (quarterly, 2026-04-30) — Basic EPS: 0.09
SYP.DE cash_flow (quarterly, 2026-04-30) — Beginning Cash Position: 2134314000.00
SYP.DE cash_flow (quarterly, 2026-04-30) — Capital Expenditure: -54198000.00
SYP.DE balance_sheet (quarterly, 2026-04-30) — Capital Lease Obligations: 805998000.00
SYP.DE balance_sheet (quarterly, 2026-04-30) — Capital Stock: 1928000.00
SYP.DE balance_sheet (quarterly, 2026-04-30) — Cash And Cash Equivalents: 2412472000.00
SYP.DE balance_sheet (quarterly, 2026-04-30) — Cash Cash Equivalents And Short Term Investments: 2484438000.00
SYP.DE cash_flow (quarterly, 2026-04-30) — Cash Flow From Continuing Financing Activities: -280952000.00
SYP.DE cash_flow (quarterly, 2026-04-30) — Cash Flow From Continuing Investing Activities: -52860000.00
SYP.DE cash_flow (quarterly, 2026-04-30) — Cash Flow From Continuing Operating Activities: 628934000.00
SYP.DE cash_flow (quarterly, 2026-04-30) — Change In Inventory: -56450000.00
SYP.DE cash_flow (quarterly, 2026-04-30) — Change In Other Current Assets: -5647000.00
SYP.DE cash_flow (quarterly, 2026-04-30) — Change In Other Current Liabilities: -41821000.00
SYP.DE cash_flow (quarterly, 2026-04-30) — Change In Other Working Capital: -208729000.00
SYP.DE cash_flow (quarterly, 2026-04-30) — Change In Payables And Accrued Expense: -77343000.00
SYP.DE cash_flow (quarterly, 2026-04-30) — Change In Prepaid Assets: -39967000.00
SYP.DE cash_flow (quarterly, 2026-04-30) — Change In Receivables: 363163000.00
SYP.DE cash_flow (quarterly, 2026-04-30) — Change In Working Capital: -66794000.00
SYP.DE cash_flow (quarterly, 2026-04-30) — Changes In Account Receivables: 363163000.00
SYP.DE cash_flow (quarterly, 2026-04-30) — Changes In Cash: 295122000.00
SYP.DE balance_sheet (quarterly, 2026-04-30) — Common Stock: 1928000.00
SYP.DE balance_sheet (quarterly, 2026-04-30) — Common Stock Equity: 30478131000.00
SYP.DE cash_flow (quarterly, 2026-04-30) — Common Stock Issuance: 103394000.00
SYP.DE income_statement (quarterly, 2026-04-30) — Cost Of Revenue: 629850000.00
SYP.DE balance_sheet (quarterly, 2026-04-30) — Current Accrued Expenses: 960927000.00
SYP.DE balance_sheet (quarterly, 2026-04-30) — Current Assets: 5437218000.00
SYP.DE balance_sheet (quarterly, 2026-04-30) — Current Capital Lease Obligation: 135523000.00
SYP.DE balance_sheet (quarterly, 2026-04-30) — Current Debt: 22117000.00
SYP.DE balance_sheet (quarterly, 2026-04-30) — Current Debt And Capital Lease Obligation: 157640000.00
SYP.DE balance_sheet (quarterly, 2026-04-30) — Current Deferred Liabilities: 2419876000.00
SYP.DE balance_sheet (quarterly, 2026-04-30) — Current Deferred Revenue: 2419876000.00
SYP.DE balance_sheet (quarterly, 2026-04-30) — Current Liabilities: 3790632000.00
SYP.DE cash_flow (quarterly, 2026-04-30) — Deferred Income Tax: -69269000.00
SYP.DE cash_flow (quarterly, 2026-04-30) — Deferred Tax: -69269000.00
SYP.DE cash_flow (quarterly, 2026-04-30) — Depreciation Amortization Depletion: 456489000.00
SYP.DE income_statement (quarterly, 2026-04-30) — Depreciation Amortization Depletion Income Statement: 155275000.00
SYP.DE cash_flow (quarterly, 2026-04-30) — Depreciation And Amortization: 456489000.00
SYP.DE income_statement (quarterly, 2026-04-30) — Depreciation And Amortization In Income Statement: 155275000.00
SYP.DE income_statement (quarterly, 2026-04-30) — Diluted Average Shares: 192144000.00
SYP.DE income_statement (quarterly, 2026-04-30) — Diluted EPS: 0.09
SYP.DE income_statement (quarterly, 2026-04-30) — Diluted NI Availto Com Stockholders: 17105000.00
SYP.DE income_statement (quarterly, 2026-04-30) — EBIT: 152640000.00
SYP.DE income_statement (quarterly, 2026-04-30) — EBITDA: 609129000.00
SYP.DE cash_flow (quarterly, 2026-04-30) — Effect Of Exchange Rate Changes: -12679000.00
SYP.DE cash_flow (quarterly, 2026-04-30) — End Cash Position: 2416757000.00
SYP.DE cash_flow (quarterly, 2026-04-30) — Financing Cash Flow: -280952000.00
SYP.DE cash_flow (quarterly, 2026-04-30) — Free Cash Flow: 574736000.00
SYP.DE income_statement (quarterly, 2026-04-30) — Gain On Sale Of Business: 0.00
SYP.DE income_statement (quarterly, 2026-04-30) — Gain On Sale Of Ppe: 0.00
SYP.DE income_statement (quarterly, 2026-04-30) — Gain On Sale Of Security: -1542000.00
SYP.DE balance_sheet (quarterly, 2026-04-30) — Gains Losses Not Affecting Retained Earnings: -244082000.00
SYP.DE income_statement (quarterly, 2026-04-30) — General And Administrative Expense: 172418000.00
SYP.DE balance_sheet (quarterly, 2026-04-30) — Goodwill: 26853807000.00
SYP.DE balance_sheet (quarterly, 2026-04-30) — Goodwill And Other Intangible Assets: 38729225000.00
SYP.DE balance_sheet (quarterly, 2026-04-30) — Gross PPE: 1411856000.00
SYP.DE income_statement (quarterly, 2026-04-30) — Gross Profit: 1646135000.00
SYP.DE balance_sheet (quarterly, 2026-04-30) — Income Tax Payable: 45020000.00
SYP.DE income_statement (quarterly, 2026-04-30) — Interest Expense: 133364000.00
SYP.DE income_statement (quarterly, 2026-04-30) — Interest Expense Non Operating: 133364000.00
SYP.DE income_statement (quarterly, 2026-04-30) — Interest Income: 12885000.00
SYP.DE income_statement (quarterly, 2026-04-30) — Interest Income Non Operating: 12885000.00
SYP.DE balance_sheet (quarterly, 2026-04-30) — Interest Payable: 42603000.00
SYP.DE balance_sheet (quarterly, 2026-04-30) — Inventory: 441836000.00
SYP.DE balance_sheet (quarterly, 2026-04-30) — Invested Capital: 40514093000.00
SYP.DE cash_flow (quarterly, 2026-04-30) — Investing Cash Flow: -52860000.00
SYP.DE cash_flow (quarterly, 2026-04-30) — Issuance Of Capital Stock: 103394000.00
SYP.DE balance_sheet (quarterly, 2026-04-30) — Long Term Capital Lease Obligation: 670475000.00
SYP.DE balance_sheet (quarterly, 2026-04-30) — Long Term Debt: 10013845000.00
SYP.DE balance_sheet (quarterly, 2026-04-30) — Long Term Debt And Capital Lease Obligation: 10684320000.00
SYP.DE cash_flow (quarterly, 2026-04-30) — Long Term Debt Payments: -11059000.00
SYP.DE balance_sheet (quarterly, 2026-04-30) — Minority Interest: -1066000.00
SYP.DE income_statement (quarterly, 2026-04-30) — Minority Interests: 237000.00
SYP.DE cash_flow (quarterly, 2026-04-30) — Net Business Purchase And Sale: 0.00
SYP.DE cash_flow (quarterly, 2026-04-30) — Net Common Stock Issuance: -159106000.00
SYP.DE balance_sheet (quarterly, 2026-04-30) — Net Debt: 7623490000.00
SYP.DE income_statement (quarterly, 2026-04-30) — Net Income: 17105000.00
SYP.DE income_statement (quarterly, 2026-04-30) — Net Income Common Stockholders: 17105000.00
SYP.DE income_statement (quarterly, 2026-04-30) — Net Income Continuous Operations: 16868000.00
SYP.DE income_statement (quarterly, 2026-04-30) — Net Income Discontinuous Operations: 0.00
SYP.DE income_statement (quarterly, 2026-04-30) — Net Income From Continuing And Discontinued Operation: 17105000.00
SYP.DE income_statement (quarterly, 2026-04-30) — Net Income From Continuing Operation Net Minority Interest: 17105000.00
SYP.DE cash_flow (quarterly, 2026-04-30) — Net Income From Continuing Operations: 16868000.00
SYP.DE income_statement (quarterly, 2026-04-30) — Net Income Including Noncontrolling Interests: 16868000.00
SYP.DE income_statement (quarterly, 2026-04-30) — Net Interest Income: -120479000.00
SYP.DE cash_flow (quarterly, 2026-04-30) — Net Investment Purchase And Sale: 1338000.00
SYP.DE cash_flow (quarterly, 2026-04-30) — Net Issuance Payments Of Debt: -11059000.00
SYP.DE cash_flow (quarterly, 2026-04-30) — Net Long Term Debt Issuance: -11059000.00
SYP.DE income_statement (quarterly, 2026-04-30) — Net Non Operating Interest Income Expense: -120479000.00
SYP.DE cash_flow (quarterly, 2026-04-30) — Net Other Financing Charges: -110787000.00
SYP.DE balance_sheet (quarterly, 2026-04-30) — Net PPE: 1411856000.00
SYP.DE cash_flow (quarterly, 2026-04-30) — Net PPE Purchase And Sale: -54198000.00
SYP.DE balance_sheet (quarterly, 2026-04-30) — Net Tangible Assets: -8251094000.00
SYP.DE balance_sheet (quarterly, 2026-04-30) — Non Current Deferred Assets: 113642000.00
SYP.DE balance_sheet (quarterly, 2026-04-30) — Non Current Deferred Liabilities: 1735691000.00
SYP.DE balance_sheet (quarterly, 2026-04-30) — Non Current Deferred Revenue: 389419000.00
SYP.DE balance_sheet (quarterly, 2026-04-30) — Non Current Deferred Taxes Assets: 113642000.00
SYP.DE balance_sheet (quarterly, 2026-04-30) — Non Current Deferred Taxes Liabilities: 877749000.00
SYP.DE income_statement (quarterly, 2026-04-30) — Normalized EBITDA: 726565000.00
SYP.DE income_statement (quarterly, 2026-04-30) — Normalized Income: 119861500.00
SYP.DE cash_flow (quarterly, 2026-04-30) — Operating Cash Flow: 628934000.00
SYP.DE income_statement (quarterly, 2026-04-30) — Operating Income: 236320000.00
SYP.DE income_statement (quarterly, 2026-04-30) — Operating Revenue: 2275985000.00
SYP.DE balance_sheet (quarterly, 2026-04-30) — Ordinary Shares Number: 191444000.00
SYP.DE balance_sheet (quarterly, 2026-04-30) — Other Current Assets: 1195391000.00
SYP.DE balance_sheet (quarterly, 2026-04-30) — Other Current Borrowings: 22117000.00
SYP.DE balance_sheet (quarterly, 2026-04-30) — Other Current Liabilities: 27912000.00
SYP.DE balance_sheet (quarterly, 2026-04-30) — Other Equity Adjustments: -244082000.00
SYP.DE income_statement (quarterly, 2026-04-30) — Other Gand A: 172418000.00
SYP.DE income_statement (quarterly, 2026-04-30) — Other Income Expense: -96565000.00
SYP.DE balance_sheet (quarterly, 2026-04-30) — Other Intangible Assets: 11875418000.00
SYP.DE cash_flow (quarterly, 2026-04-30) — Other Non Cash Items: 62701000.00
SYP.DE balance_sheet (quarterly, 2026-04-30) — Other Non Current Assets: 1197086000.00
SYP.DE balance_sheet (quarterly, 2026-04-30) — Other Non Current Liabilities: 201319000.00
SYP.DE income_statement (quarterly, 2026-04-30) — Other Non Operating Income Expenses: 20871000.00
SYP.DE balance_sheet (quarterly, 2026-04-30) — Other Properties: 1411856000.00
SYP.DE balance_sheet (quarterly, 2026-04-30) — Other Short Term Investments: 71966000.00
SYP.DE balance_sheet (quarterly, 2026-04-30) — Payables: 224277000.00
SYP.DE balance_sheet (quarterly, 2026-04-30) — Payables And Accrued Expenses: 1185204000.00
SYP.DE balance_sheet (quarterly, 2026-04-30) — Preferred Stock: 0.00
SYP.DE income_statement (quarterly, 2026-04-30) — Pretax Income: 19276000.00
SYP.DE cash_flow (quarterly, 2026-04-30) — Provisionand Write Offof Assets: 6636000.00
SYP.DE cash_flow (quarterly, 2026-04-30) — Purchase Of Investment: -9780000.00
SYP.DE cash_flow (quarterly, 2026-04-30) — Purchase Of PPE: -54198000.00
SYP.DE balance_sheet (quarterly, 2026-04-30) — Receivables: 1267305000.00
SYP.DE income_statement (quarterly, 2026-04-30) — Reconciled Cost Of Revenue: 328636000.00
SYP.DE income_statement (quarterly, 2026-04-30) — Reconciled Depreciation: 456489000.00
SYP.DE cash_flow (quarterly, 2026-04-30) — Repayment Of Debt: -11059000.00
SYP.DE income_statement (quarterly, 2026-04-30) — Research And Development: 700124000.00
SYP.DE income_statement (quarterly, 2026-04-30) — Restructuring And Mergern Acquisition: 115894000.00
SYP.DE balance_sheet (quarterly, 2026-04-30) — Retained Earnings: 10397550000.00
SYP.DE cash_flow (quarterly, 2026-04-30) — Sale Of Business: 0.00
SYP.DE cash_flow (quarterly, 2026-04-30) — Sale Of Investment: 11118000.00
SYP.DE income_statement (quarterly, 2026-04-30) — Selling And Marketing Expense: 381998000.00
SYP.DE income_statement (quarterly, 2026-04-30) — Selling General And Administration: 554416000.00
SYP.DE balance_sheet (quarterly, 2026-04-30) — Share Issued: 192037000.00
SYP.DE income_statement (quarterly, 2026-04-30) — Special Income Charges: -115894000.00
SYP.DE cash_flow (quarterly, 2026-04-30) — Stock Based Compensation: 222303000.00
SYP.DE balance_sheet (quarterly, 2026-04-30) — Stockholders Equity: 30478131000.00
SYP.DE balance_sheet (quarterly, 2026-04-30) — Tangible Book Value: -8251094000.00
SYP.DE income_statement (quarterly, 2026-04-30) — Tax Effect Of Unusual Items: -14679500.00
SYP.DE income_statement (quarterly, 2026-04-30) — Tax Provision: 2408000.00
SYP.DE income_statement (quarterly, 2026-04-30) — Tax Rate For Calcs: 0.13
SYP.DE balance_sheet (quarterly, 2026-04-30) — Total Assets: 46889027000.00
SYP.DE balance_sheet (quarterly, 2026-04-30) — Total Capitalization: 40491976000.00
SYP.DE balance_sheet (quarterly, 2026-04-30) — Total Debt: 10841960000.00
SYP.DE balance_sheet (quarterly, 2026-04-30) — Total Equity Gross Minority Interest: 30477065000.00
SYP.DE income_statement (quarterly, 2026-04-30) — Total Expenses: 2039665000.00
SYP.DE balance_sheet (quarterly, 2026-04-30) — Total Liabilities Net Minority Interest: 16411962000.00
SYP.DE balance_sheet (quarterly, 2026-04-30) — Total Non Current Assets: 41451809000.00
SYP.DE balance_sheet (quarterly, 2026-04-30) — Total Non Current Liabilities Net Minority Interest: 12621330000.00
SYP.DE income_statement (quarterly, 2026-04-30) — Total Operating Income As Reported: 120426000.00
SYP.DE balance_sheet (quarterly, 2026-04-30) — Total Tax Payable: 45020000.00
SYP.DE income_statement (quarterly, 2026-04-30) — Total Unusual Items: -117436000.00
SYP.DE income_statement (quarterly, 2026-04-30) — Total Unusual Items Excluding Goodwill: -117436000.00
SYP.DE balance_sheet (quarterly, 2026-04-30) — Treasury Shares Number: 593000.00
SYP.DE balance_sheet (quarterly, 2026-04-30) — Treasury Stock: 242827000.00
SYP.DE balance_sheet (quarterly, 2026-04-30) — Working Capital: 1646586000.00
SYPR cash_flow (annual, 2021-12-31) — Net Other Investing Changes: 10000.00
SYPR cash_flow (annual, 2021-12-31) — Operating Gains Losses: -3588000.00
SYPR balance_sheet (annual, 2021-12-31) — Other Current Liabilities: 336000.00
SYPR balance_sheet (annual, 2021-12-31) — Other Non Current Liabilities: 101000.00
SYPR income_statement (annual, 2021-12-31) — Other Special Charges: -3599000.00
SYPR income_statement (annual, 2021-12-31) — Special Income Charges: 3599000.00
SYPR income_statement (annual, 2021-12-31) — Total Unusual Items: 3599000.00
SYPR income_statement (annual, 2021-12-31) — Total Unusual Items Excluding Goodwill: 3599000.00
SYPR income_statement (annual, 2022-12-31) — +Operating Expense: 14489000.00
SYPR income_statement (annual, 2022-12-31) — +Total Revenue: 110121000.00
SYPR balance_sheet (annual, 2022-12-31) — Accounts Payable: 17638000.00
SYPR balance_sheet (annual, 2022-12-31) — Accounts Receivable: 8064000.00
SYPR balance_sheet (annual, 2022-12-31) — Accumulated Depreciation: -60640000.00
SYPR balance_sheet (annual, 2022-12-31) — Additional Paid In Capital: 155535000.00
SYPR balance_sheet (annual, 2022-12-31) — Allowance For Doubtful Accounts Receivable: -75000.00
SYPR income_statement (annual, 2022-12-31) — Basic Average Shares: 21729000.00
SYPR income_statement (annual, 2022-12-31) — Basic EPS: -0.11
SYPR cash_flow (annual, 2022-12-31) — Beginning Cash Position: 11620000.00
SYPR balance_sheet (annual, 2022-12-31) — Buildings And Improvements: 8044000.00
SYPR cash_flow (annual, 2022-12-31) — Capital Expenditure: -3041000.00
SYPR cash_flow (annual, 2022-12-31) — Capital Expenditure Reported: -3041000.00
SYPR balance_sheet (annual, 2022-12-31) — Capital Lease Obligations: 8516000.00
SYPR balance_sheet (annual, 2022-12-31) — Capital Stock: 221000.00
SYPR balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 21648000.00
SYPR balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Short Term Investments: 21648000.00
SYPR cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Financing Activities: -1383000.00
SYPR cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Investing Activities: -3031000.00
SYPR cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Operating Activities: 13793000.00
SYPR cash_flow (annual, 2022-12-31) — Change In Account Payable: 5556000.00
SYPR cash_flow (annual, 2022-12-31) — Change In Accrued Expense: 20409000.00
SYPR cash_flow (annual, 2022-12-31) — Change In Inventory: -11804000.00
SYPR cash_flow (annual, 2022-12-31) — Change In Payable: 5556000.00
SYPR cash_flow (annual, 2022-12-31) — Change In Payables And Accrued Expense: 25965000.00
SYPR cash_flow (annual, 2022-12-31) — Change In Prepaid Assets: -3072000.00
SYPR cash_flow (annual, 2022-12-31) — Change In Receivables: 345000.00
SYPR cash_flow (annual, 2022-12-31) — Change In Working Capital: 11434000.00
SYPR cash_flow (annual, 2022-12-31) — Changes In Account Receivables: 345000.00
SYPR cash_flow (annual, 2022-12-31) — Changes In Cash: 9379000.00
SYPR balance_sheet (annual, 2022-12-31) — Common Stock: 221000.00
SYPR balance_sheet (annual, 2022-12-31) — Common Stock Equity: 19575000.00
SYPR cash_flow (annual, 2022-12-31) — Common Stock Payments: -49000.00
SYPR balance_sheet (annual, 2022-12-31) — Construction In Progress: 2048000.00
SYPR income_statement (annual, 2022-12-31) — Cost Of Revenue: 95268000.00
SYPR balance_sheet (annual, 2022-12-31) — Current Accrued Expenses: 4010000.00
SYPR balance_sheet (annual, 2022-12-31) — Current Assets: 79978000.00
SYPR balance_sheet (annual, 2022-12-31) — Current Capital Lease Obligation: 2270000.00
SYPR balance_sheet (annual, 2022-12-31) — Current Debt: 2898000.00
SYPR balance_sheet (annual, 2022-12-31) — Current Debt And Capital Lease Obligation: 5168000.00
SYPR balance_sheet (annual, 2022-12-31) — Current Deferred Liabilities: 28214000.00
SYPR balance_sheet (annual, 2022-12-31) — Current Deferred Revenue: 28214000.00
SYPR balance_sheet (annual, 2022-12-31) — Current Liabilities: 56122000.00
SYPR cash_flow (annual, 2022-12-31) — Deferred Income Tax: 329000.00
SYPR cash_flow (annual, 2022-12-31) — Deferred Tax: 329000.00
SYPR balance_sheet (annual, 2022-12-31) — Defined Pension Benefit: 645000.00
SYPR cash_flow (annual, 2022-12-31) — Depreciation Amortization Depletion: 3088000.00
SYPR cash_flow (annual, 2022-12-31) — Depreciation And Amortization: 3088000.00
SYPR income_statement (annual, 2022-12-31) — Diluted Average Shares: 21729000.00
SYPR income_statement (annual, 2022-12-31) — Diluted EPS: -0.11
SYPR income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: -2494000.00
SYPR income_statement (annual, 2022-12-31) — EBIT: -436000.00
SYPR income_statement (annual, 2022-12-31) — EBITDA: 2652000.00
SYPR cash_flow (annual, 2022-12-31) — Effect Of Exchange Rate Changes: 649000.00
SYPR balance_sheet (annual, 2022-12-31) — Employee Benefits: 4332000.00
SYPR cash_flow (annual, 2022-12-31) — End Cash Position: 21648000.00
SYPR cash_flow (annual, 2022-12-31) — Financing Cash Flow: -1383000.00